Literature DB >> 30939093

Staging the Metastatic Spectrum Through Integration of Clinical and Molecular Features.

Corey C Foster1, Sean P Pitroda1, Ralph R Weichselbaum1.   

Abstract

Year:  2019        PMID： 30939093     DOI： 10.1200/JCO.18.02021

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Local consolidative therapy for oligometastatic patients with stage IV non-small cell lung cancer may improve survival, but unanswered questions remain.

Authors:  Jose M Pacheco; Drew Moghanaki
Journal:  Transl Lung Cancer Res       Date:  2019-12

Review 2.  Circulating Tumor DNA Biomarkers for Early Detection of Oligometastasis.

Authors:  David M Routman; Bhishamjit S Chera; Gaorav P Gupta
Journal:  Cancer J       Date:  2020 Mar/Apr       Impact factor: 2.074

3.  Late Brain Oligometastases Diagnosed at Least 36 Months after Cancer Detection are Associated with Favorable Survival Outcome.

Authors:  Carsten Nieder; Bård Mannsåker; Rosalba Yobuta
Journal:  Cureus       Date:  2020-01-03

4.  Commentary: When cancer is oligometastatic, even mesothelioma is curable.

Authors:  Abbas E Abbas
Journal:  JTCVS Tech       Date:  2020-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.